Speakers

Laurie Mischley, ND PhD MPH studied naturopathic medicine (ND) at Bastyr University and epidemiology (MPH) and nutritional sciences (PhD) at the University of Washington and she maintains appointments at both Universities. Her work is focused on identifying the nutritional requirements unique to individuals with Parkinson’s Disease (PD) and has published on coenzyme Q10, lithium, NAD+, and glutathione deficiency (www.lauriemischley.com). She is Principal Investigator of the Modifiable Variables in Parkinsonism (MVP) Study (MVP-study.com), which is attempting to describe why some people with PD progress slower than others. She is working on ways to study, package and deliver evidence-based lifestyle modification as a therapeutic strategy. She founded the Parkinson Center for Pragmatic Research (www.parkinson-cpr.com) and the canine scent-based PD screening tool, ParK-9 (www.Park-9.com), developed a patient-reported outcome measure to assess PD severity (www.PD-symptoms.com), built the Parkinson Symptom Tracking (PRO-PD) App, and is instructor of the online series, Parkinson School (www.Parkinson-School.com). Dr. Mischley maintains a small clinical practice at Seattle Integrative Medicine focused on nutrition and neurological health of patients with Parkinsonism. 

Roger Barker is the Professor of Clinical Neuroscience at the University of Cambridge and Consultant Neurologist at Addenbrooke's Hospital. He runs the regional NHS Huntington's Disease (HD) as well as clinics in Parkinson's Disease (PD). His research investigates the heterogeneity of these disorders and its basis which has informed work he has done on trialing new experimental therapeutics for these conditions including cell and gene therapies as well as drug repurposing. He is lead academic scientist of the ARUK funded Drug Discovery Institute in Cambridge as well as the John Van Geest Centre for Brain Repair. He is Co-editor in chief of the Journal of Neurology.